All In MedTech

FDA Clearance Tracker · P830039-S007

OMNICARBON CARDIAC VALVE PROSTHESIS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 26, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 26, 2001

Approved

Time to decision

1,736 days

Received Oct 24, 1996. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P830039-S007
Device name
OMNICARBON CARDIAC VALVE PROSTHESIS
Applicant location
Inver Grove Heights, MN
Received
Oct 24, 1996
Decided
Jul 26, 2001
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P830039

Device type

Device class
Class III

Every decision under product code LWQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE OMNICARBON(TM) CARDIAC VALVE PROSTHESIS, AORTIC MODEL 3313 IN SIZES 23, 25, 27, AND 29 MM, AND MITRAL SUPRA-ANNULAR MODEL 3523 IN SIES 27, 29, 31, AND 33 MM. THE DEVICE IS INDICATED FOR THE REPLACEMENT OF DYSFUNCTIONING NATIVE OR PROSTHETIC AORTIC OR MITRAL HEART VALVES.

Source documents

Other decisions for Medical Cv, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.